Athos Therapeutics Announces The Completion Of Its Oversubscribed Series A Financing
Round Type
Series A
TorranceBiotechnologyHealthcareHealth CareScience And EngineeringDescription
Athos Therapeutics, Inc., a late preclinical stage biotechnology company pioneering the development of first-in-class precision therapeutics for patients with autoimmune diseases and cancer, announced today the completion of an oversubscribed $15MM Series A financing.
Quick answer
Athos Therapeutics, Inc. raised an undisclosed amount in a Series A round, dated November 15, 2021. Athos Therapeutics, Inc. is based in Torrance, California, United States.
- How much did Athos Therapeutics, Inc. raise?
- Athos Therapeutics, Inc. raised an undisclosed amount in a Series A round on November 15, 2021.
- What does Athos Therapeutics, Inc. do?
- Athos Therapeutics Inc. is a late-stage preclinical biotech company developing small molecule therapeutics for immune-mediated diseases and cancer using artificial intelligence-generated innovative chemistry and..
- Where is Athos Therapeutics, Inc. based and how big is it?
- Athos Therapeutics, Inc. is based in Torrance, California, United States.
- Who are the decision-makers at Athos Therapeutics, Inc?
- Fundz holds 1 contact at Athos Therapeutics, Inc., including the Executive Officer, Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Science And Engineering around the same time
Companies in the same sectors as Athos Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.
- SEELOS THERAPEUTICS, INC. raised $20M (Convertible Note) on November 24, 2021.
- RedHill Biopharma Ltd raised $5M on November 22, 2021.
- RedHill Biopharma Ltd raised an undisclosed amount (Corporate Round) on November 8, 2021.
- Trait Biosciences Inc. raised an undisclosed amount (Series A) on December 30, 2021.
- Arbutus raised $15M on December 30, 2021.
- Venus Concept Inc. raised $12M on December 30, 2021.
Who to call at Athos Therapeutics, Inc., and when
A new round usually means Athos Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Athos Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Athos Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Athos Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Athos Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAthos Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.